News Center

Home page

Peak Report

News reports

Supplementary Announcement on Correction of 2017 Annual General Meeting of Shareholders

Release time:

2020-08-05

证券代码：600668 证券简称：尖峰集团公告编号：2018-011

浙江尖峰集团股份有限公司

关于2017年年度股东大会更正补充公告

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。

一、股东大会有关情况

1. 原股东大会的类型和届次：

2017年年度股东大会

2. 原股东大会召开日期：2018年5月18日

3. 原股东大会股权登记日：

股份类别	股票代码	股票简称	股权登记日
Ａ股	600668	尖峰集团	2018/5/11

二、更正补充事项涉及的具体内容和原因

浙江尖峰集团股份有限公司（以下简称“公司”）于2018年4月24日在上海证券交易所网站（http://www.sse.com.cn/）披露了《关于召开2017年年度股东大会的通知》，通知中“会议审议事项”及《授权委托书》（附件1）的议案“序号”的格式不准确，现更正如下：

（一）关于对“会议审议事项”议案“序号”的更正

原文为：

序号	议案名称	投票股东类型
序号	议案名称	A股股东
非累积投票议案
1.00	审议2017年度董事会工作报告；	√
1.01	审议2017年度监事会工作报告；	√
1.02	审议2017年度财务决算报告；	√
1.03	审议2017年度利润分配议案；	√
1.04	审议聘请公司2018年度审计机构的议案；	√
1.05	审议对控股子公司提供担保的议案；	√
1.06	审议2017年年度报告及其摘要；	√

现更正为：

序号	议案名称	投票股东类型
序号	议案名称	A股股东
非累积投票议案
1	审议2017年度董事会工作报告；	√
2	审议2017年度监事会工作报告；	√
3	审议2017年度财务决算报告；	√
4	审议2017年度利润分配议案；	√
5	审议聘请公司2018年度审计机构的议案；	√
6	审议对控股子公司提供担保的议案；	√
7	审议2017年年度报告及其摘要；	√

（二）关于对《授权委托书》（附件1）议案“序号”的更正

原文为：

序号	非累积投票议案名称	同意	反对	弃权
1.00	审议2017年度董事会工作报告；
1.01	审议2017年度监事会工作报告；
1.02	审议2017年度财务决算报告；
1.03	审议2017年度利润分配议案；
1.04	审议聘请公司2018年度审计机构的议案；
1.05	审议对控股子公司提供担保的议案；
1.06	审议2017年年度报告及其摘要；

更正为：

序号	非累积投票议案名称	同意	反对	弃权
1	审议2017年度董事会工作报告；
2	审议2017年度监事会工作报告；
3

More information

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-30

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Daye Jianfeng Cement Co., Ltd. Kiln End Flue Gas Desulfurization Project Completion Environmental Protection Acceptance Publicity

Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution

2020

07-31

Spike New Drug Approved for Registration

On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)

2020

07-31

Spike New Drug Approved for Registration

2020

07-31

< 1...30 31 32...61 > 跳转到页